Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Case Studies01:22

Case Studies

There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pedigree Analysis01:35

Pedigree Analysis

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four-day versus five-day blood culture incubation: a prospective study of diagnostic performance using the bioMérieux BACT/ALERT VIRTUO system.

BMC infectious diseases·2026
Same author

Harmonization of Health Data Governance, Oversight, and Policy: Reimagining Stewardship.

Healthcare management forum·2026
Same author

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project.

Cancers·2026
Same author

Genomic newborn screening: a scoping review of the field's evolution and associated ethical, legal, and social implications.

European journal of human genetics : EJHG·2026
Same author

Genomic newborn screening: data retention for research and clinical reuse.

European journal of human genetics : EJHG·2026
Same author

Canadian Women's Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project.

Clinical breast cancer·2026

Related Experiment Video

Updated: Jun 2, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Paediatric biobanks: what makes them so unique?

Julie Samuël1, Bartha M Knoppers, Denise Avard

  • 1FRSQ, Quebec, Canada.

Journal of Paediatrics and Child Health
|May 4, 2011
PubMed
Summary

Paediatric biobanks are crucial for child health research but need unique policies. Adapting consent, result return, and privacy for children is essential to protect their rights.

Area of Science:

  • Biobanking and Biomedical Research
  • Pediatric Health and Development
  • Research Ethics and Governance

Background:

  • Paediatric biobanks collect and manage biological samples from children, vital for studying child development, health, and behavior.
  • Existing international norms for adult biobanks are insufficient for paediatric biobanks due to children's unique needs and evolving capacities.

Purpose of the Study:

  • To highlight the necessity for distinct policies in paediatric biobanks.
  • To re-examine and propose adaptations for consent, return of research results, and privacy within the paediatric biobanking context.
  • To ensure the rights and welfare of child participants are prioritized over extrapolating adult-based norms.

Main Methods:

  • Review and critical analysis of existing biobanking norms.

More Related Videos

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Related Experiment Videos

Last Updated: Jun 2, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

  • Discussion of specific ethical and logistical considerations for paediatric biobanks.
  • Exploration of modulated approaches to consent, result return, and privacy for child participants.

    • Main Results:

    • Paediatric biobanks require tailored policies addressing children's specific vulnerabilities and developmental stages.
    • Modifications in consent, return of research results, and privacy are necessary for ethical paediatric biobanking.
    • Adapting policies, despite potential financial and logistical challenges, is crucial for safeguarding child participants' rights.

    Conclusions:

    • Paediatric biobanks must develop unique management policies, not simply adapt adult-centric guidelines.
    • Prioritizing the distinct ethical and developmental needs of children is paramount in biobank governance.
    • Proactive adaptation of policies is essential to uphold the rights and welfare of child donors in research.